Edith Vaquero

ORCID: 0000-0003-0634-6064
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cutaneous Melanoma Detection and Management
  • Melanoma and MAPK Pathways
  • AI in cancer detection
  • Immunotherapy and Immune Responses
  • Computational Drug Discovery Methods
  • Protein Degradation and Inhibitors
  • Cell Adhesion Molecules Research
  • Cancer Mechanisms and Therapy
  • Multiple Myeloma Research and Treatments
  • Cancer-related Molecular Pathways
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Glioma Diagnosis and Treatment
  • Advanced Breast Cancer Therapies
  • Cytokine Signaling Pathways and Interactions

California Pacific Medical Center
2018-2023

Abstract Cholangiocarcinoma (CCA) is a highly invasive cancer, diagnosed at an advanced stage, and refractory to surgical intervention chemotherapy. Cyclin-dependent kinases (CDKs) regulate cell cycle progression transcriptional processes, are considered potential therapeutic targets for cancer. Dinaciclib small molecule multi-CDK inhibitor targeting CDK 2/5/9. In this study, the efficacy of dinaciclib was assessed using patient-derived xenograft cells (PDXC) CCA lines. Treatment with...

10.1038/s41598-020-75578-5 article EN cc-by Scientific Reports 2020-10-28

Glioblastoma’s (GBM) aggressive growth is driven by redundant activation of a myriad signaling pathways and genomic alterations in tyrosine kinase receptors, such as epidermal factor receptor (EGFR), which altered over 50% cases. Single agents targeting EGFR have not proven effective against GBM. In this study, we aimed to identify an anti-tumor regimen using pharmacogenomic testing patient-derived GBM samples, culture vivo. High-throughput pharmacological screens ten EGFR-driven samples...

10.3390/cells12040547 article EN cc-by Cells 2023-02-08

Purpose: Previous studies have indicated an important role for pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. Here we aimed to confirm the PHIP copy number in successive stages progression.Experimental Design:PHIP was examined using FISH three independent cohorts by recording percentage cells harboring ≥3 copies The impact on survival assessed Cox regression analysis. enrichment various molecular subtypes. expression analyzed Cancer...

10.1158/1078-0432.ccr-18-0791 article EN Clinical Cancer Research 2018-05-18

Technetium-99m-labeled Tilmanocept, a multivalent mannose, is readily internalized by the CD206 surface receptor on macrophages and dendritic cells which are abundantly present in lymph nodes. We want to examine drainage patterns of Tilmanocept sentinel nodes (SLNs) melanoma patients following 10% rule.Multi-center retrospective review with cutaneous undergoing SLN biopsy using between 2008 2014 was conducted. Statistical methods were used for data analyses.Of 564 (mean age 60.3 62% male)...

10.1177/10732748231153775 article EN cc-by-nc Cancer Control 2023-01-01

<div>Abstract<p><b>Purpose:</b> Previous studies have indicated an important role for pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. Here we aimed to confirm the <i>PHIP</i> copy number in successive stages progression.</p><p><b>Experimental Design:</b> was examined using FISH three independent cohorts by recording percentage cells harboring ≥3 copies <i>PHIP</i>....

10.1158/1078-0432.c.6527432.v1 preprint EN 2023-03-31

<div>Abstract<p><b>Purpose:</b> Previous studies have indicated an important role for pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. Here we aimed to confirm the <i>PHIP</i> copy number in successive stages progression.</p><p><b>Experimental Design:</b> was examined using FISH three independent cohorts by recording percentage cells harboring ≥3 copies <i>PHIP</i>....

10.1158/1078-0432.c.6527432 preprint EN 2023-03-31
Coming Soon ...